Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinical relevance of chest computed tomography imaging in pulmonary hypertension associated with lung diseases.

Current opinion in pulmonary medicine - 1 Sept 2026

Johnson Shelsey W, Rahaghi Farbod N, Estépar Raul San Jose

Abstract excerpt

PURPOSE OF REVIEW: The purpose of this review is to describe the use of chest computed tomography (CT) data to expand sub-phenotyping of pulmonary hypertension associated with chronic lung disease (Group 3 pulmonary hypertension) and inform identification of effective treatment. RECENT FINDINGS: In the last 5 years, breakthroughs in clinical pulmonary hypertension research highlight the importance of chest CT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Relevance
Share to Hypertension, Pulmonary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Diseases

Share to Phenotype

Share to Tomography, X-Ray Computed

Source

Open in PubMed Open full text

Identifiers

PMID: 42083403
DOI: 10.1097/MCP.0000000000001282
PMCID: PMC13270433

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinical relevance of chest computed tomography imaging in pulmonary hypertension associated with lung diseases.PMID 42083403Read ↗

Phenotypes in pulmonary hypertension.Semantic proximity Read ↗

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative ‐ Group 3 Pulmonary HypertensionSemantic proximity Read ↗

An official American Thoracic Society Statement: pulmonary hypertension phenotypes.Semantic proximity Read ↗

Cardiac MRI differentiates classical idiopathic pulmonary arterial hypertension from lung phenotype and group 3 pulmonary hypertension.Semantic proximity Read ↗

Severe pulmonary hypertension in lung disease: phenotypes and response to treatment.Semantic proximity Read ↗

Genetic variants in pulmonary hypertension associated with chronic obstructive pulmonary disease.Semantic proximity Read ↗

Idiopathic pulmonary fibrosis: phenotypes and comorbidities.Semantic proximity Read ↗

Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertensionSemantic proximity Read ↗

Exercise Induced Pulmonary Hypertension: What is New?Semantic proximity Read ↗

Thoracic computed tomography in the progressive fibrotic phenotype.Semantic proximity Read ↗

Pulmonary CT and MRI phenotypes that help explain chronic pulmonary obstruction disease pathophysiology and outcomes.Semantic proximity Read ↗

Prognostic Role and Determinants of Ascending Aorta Dilatation in Non-Advanced Idiopathic Pulmonary Fibrosis: A Preliminary Observation from a Tertiary University CentreSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.